NCT06096688Recruiting
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Discovering New Targets for Hereditary and Sporadic Colorectal and Endometrial Cancer Risk Reduction
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1120 (estimated)
- First submitted
- 17 Oct 2023
- Start date
- 29 May 2019
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Weill Medical College of Cornell University
- Diseases
- Endometrial cancer, Colorectal cancer
- NCT number
- NCT06096688
What you commit to
- Study type: Observational
- Planned participants: 1120
- From 29 May 2019 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- The following eligibility criteria must be met as follows:
- Age ≥ 18 years old.
- One of the following must be met:
- Diagnosis of a Hereditary Cancer Syndrome by positive genetic testing and/or clinical criteria to undergo an endoscopy procedure (esophagoduodenoscopy and/or colonoscopy/flexible sigmoidoscopy), or endometrial screening procedure (transvaginal ultrasound and/or hysteroscopy and/or endometrial biopsy), OR
- Individuals coming to Weill-Cornell Medicine/NYPH to undergo an endoscopy procedure, transvaginal ultrasound, or hysteroscopy for average-risk (population-based) recommendation OR
- Individuals diagnosed with colorectal cancer or endometrial cancer coming to Weill- Cornell Medicine/NYPH for surgical treatment OR
- Individuals coming to Weill-Cornell Medicine/NYPH for care such as, but not limited to, diagnostic testing, clinic and/or treatment visit.
- Willingness and ability to sign informed consent.
- Ability to read/understand English, Spanish, and/or simplified Chinese.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYP/Weill Cornell Medicine Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.